Evaluation of the efficacy of rosuvastatin in daily practice in untreated high risk patients (CHALLENGE) - CHALLENGE

Study identifier:NL950057

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Evaluation of the efficacy of rosuvastatin in daily practice in untreated high risk patients (CHALLENGE)

Medical condition

Hypercholesterolemia

Phase

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

2660

Study type

Observational

Age

18 Years +

Date

Study Start Date: 01 Sept 2003

Primary Completion Date: -

Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions

Documents available

https://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=1089&filename=CSR-NL950057.pdf
Download
CSR-NL950057.pdf
Download
Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca The Neatherlands Clincial Study

+31 79 363 2284

[email protected]

Investigators

Principal Investigator

Ingrid van Geel